These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8729757)

  • 21. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.
    Oliveri F; Santantonio T; Bellati G; Colombatto P; Mels GC; Carriero L; Dastoli G; Pastore G; Ideo G; Bonino F; Brunetto MR
    Am J Gastroenterol; 1999 May; 94(5):1366-72. PubMed ID: 10235220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Appearance of anti-DNA antibodies after treatment with interferon in a patient with chronic type C viral hepatitis].
    Ballardini P; Cicognani I; Montanari E; Fabbri F; Ferrari R; Del Noce A
    Riv Eur Sci Med Farmacol; 1995; 17(4):131-2. PubMed ID: 8545566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy.
    Custro N; Montalto G; Scafidi V; Soresi M; Gallo S; Tripi S; Notarbartolo A
    J Endocrinol Invest; 1997; 20(7):374-80. PubMed ID: 9309534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
    Hass HG; Klein R; Nehls O; Kaiser S
    J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence and significance of non-specific anti-organelle antibodies of the liver in chronic viral hepatitis C].
    Borotto E; Lunel F; Valla D; Abuaf N; Perrin M; Bousquet JC; Opolon P; Homberg JC
    Gastroenterol Clin Biol; 1994; 18(10):813-8. PubMed ID: 7875387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis.
    Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E
    Am J Gastroenterol; 1990 Jan; 85(1):24-9. PubMed ID: 1688684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-interferon antibody in chronic hepatitis C].
    Arai K; Shindo M; Okuno T
    Nihon Rinsho; 1994 Jul; 52(7):1929-34. PubMed ID: 7521441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
    Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
    Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis.
    Jicha DL; Davis GL; Peters MG; Hoofnagle JH; Jones EA
    J Interferon Res; 1986 Feb; 6(1):13-20. PubMed ID: 3084673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
    Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy.
    Tran A; Quaranta JF; Benzaken S; Thiers V; Chau HT; Hastier P; Regnier D; Dreyfus G; Pradier C; Sadoul JL
    Hepatology; 1993 Aug; 18(2):253-7. PubMed ID: 7687977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
    Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
    Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis].
    Karino Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.